Quick answer
Treatment-resistant depression usually means depression that hasn't improved enough after at least two antidepressants. Before accepting that label, it's worth checking whether each trial lasted long enough, whether the diagnosis is right (bipolar disorder, for example, can be missed), and whether medical problems, alcohol or ongoing stress are playing a part. If those check out, options include adjusting or switching medication, adding another medication, adding structured psychotherapy, and, in some cases, a referral for brain stimulation treatments such as TMS or ECT. The label describes a treatment history, not a verdict about you.
Key takeaways
- Treatment-resistant depression describes a treatment history, not a statement about you, and it doesn't mean nothing will work.
- Before accepting the label, it's worth checking whether past medication trials were adequate and whether the diagnosis is correct.
- Medical contributors, alcohol use and ongoing life stressors can all keep depression going and are worth evaluating.
- A second opinion that revisits the diagnosis and treatment history with fresh attention often changes the picture.
Treatment-resistant depression, or TRD, is generally defined as depression that hasn’t improved enough after at least two antidepressants, each given a fair trial. It is not rare, and in a large study, many people who didn’t improve with their first antidepressant did improve at a later treatment step.
For the person experiencing it, the label often lands badly. It sounds like a verdict. Before accepting it as one, several things are worth examining, and a psychiatric evaluation in New Jersey that revisits the fundamentals frequently changes the picture.
Before Accepting a TRD Diagnosis
The term assumes the treatment was adequate and the diagnosis was correct. Both assumptions deserve scrutiny.
Was the trial actually a fair one? Antidepressants usually take 4 to 8 weeks for full benefit, though some improvement often starts in the first 2 weeks. Some trials that are counted as failures were stopped early because of side effects or taken inconsistently. A medication taken for only a few weeks has not failed. It has not been fully tested.
Is the diagnosis correct? This is the most consequential question. Unrecognized bipolar spectrum disorder is one important reason antidepressants may not work — antidepressants used alone in bipolar disorder may not work well and can trigger a manic episode or rapid cycling. Unrecognized ADHD, trauma-related conditions and personality disorders can also cause symptoms that look like depression and may not improve with antidepressants alone.
Is something medical contributing? Thyroid problems, low B12 or iron, sleep apnea and certain medications can cause or worsen depression symptoms. Low vitamin D has been linked with depression, but in a large trial vitamin D supplements didn’t prevent it. These are straightforward to evaluate and are sometimes the entire explanation.
Is substance use involved? Alcohol in particular can worsen depression and get in the way of treatment, and its role is easy to underestimate.
Is there an untreated maintaining factor? An abusive relationship, chronic pain, financial crisis, or unaddressed trauma will limit what medication can accomplish.
When people describe cycling through medications without improvement, the medication is often not the problem. The formulation of the problem is. This is a reasonable basis to seek a second opinion rather than a fourth medication trial. Looking for a second-opinion psychiatrist in New Jersey? Our providers are board-certified psychiatric nurse practitioners (PMHNPs), who provide psychiatric evaluation and medication management. They can take a fresh look at the diagnosis and your treatment history.
What Adequate Treatment Actually Requires
Where the diagnosis is confirmed and the trials were genuinely adequate, the evidence-based options are broader than most people are told.
Adjusting the current plan. Sometimes the current medication isn’t yet working as well as it could, and your provider may adjust it before considering a switch.
Switching. Moving to a different antidepressant, of the same type or a different type. One not working doesn’t mean another won’t.
Adding a medication. Another option is combining an antidepressant with a different type of medication that may make it more effective, such as an antipsychotic or an anticonvulsant.
Combining with psychotherapy. Where medication alone has been the approach, adding structured psychotherapy can help, and it is sometimes overlooked. We don’t offer standalone weekly therapy, but we’re happy to help you find a therapist and, with your permission, we’ll coordinate with them.
Newer and More Intensive Options
For depression that persists through several adequate trials, additional options exist.
Esketamine. Esketamine, a nasal spray, is FDA-approved for treatment-resistant depression. It’s given only in certified treatment centers, with monitoring for at least 2 hours afterward, so it isn’t prescribed for home use. We can talk about whether a referral makes sense.
Transcranial magnetic stimulation. TMS is a noninvasive, FDA-approved outpatient treatment for treatment-resistant depression, delivered over a course of several weeks. It does not involve anesthesia.
Electroconvulsive therapy. ECT is an established, FDA-approved treatment, generally used for severe depression after other treatments have been tried, or sooner when severe depression is life-threatening. Its reputation substantially predates modern practice, and it is worth discussing accurately rather than dismissing.
Brain stimulation treatments such as TMS and ECT are most often used when depression hasn’t improved enough with antidepressant medication, often after two or more trials. ECT may be considered earlier for severe depression, such as when there is psychosis or a high risk of suicide. Insurance coverage criteria vary. Whether a referral makes sense depends on your situation, and your provider will talk with you about all your options.
Treatment history
Your treatment history, in one place
Tick what you can gather or answer, then copy your list to bring to your provider. Nothing is saved or sent.
What This Means If You Are in It
The most important point is that TRD is a description of a treatment history, not a statement about a person. It does not mean nothing will work. It frequently means that something in the formulation has not yet been identified.
The people who do best are generally those whose diagnosis gets revisited rather than assumed, whose medical contributors get evaluated, and whose treatment history gets reconstructed carefully enough to distinguish genuine failures from inadequate trials.
Check your understanding
Three quick questions
1Someone took an antidepressant for three weeks, then stopped. What does that tell you?
Antidepressants usually take 4 to 8 weeks for full benefit, though some improvement often starts in the first 2 weeks. Three weeks isn't a fair test: the medication hasn't failed, it hasn't been fully tested.
2Which question does this article call the most consequential when antidepressants haven't worked?
Bipolar disorder that hasn't been recognized is one important reason: antidepressants used alone in bipolar disorder may not work and can trigger a manic episode or rapid cycling. Other conditions can also look like depression.
3If one SSRI (a common type of antidepressant) didn't help, will the others fail too?
Switching, within the same type or to a different one, is a standard next step. Plan any switch with your provider. Please don't stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly. In short-term studies, antidepressants increased suicidal thoughts and behaviors in people up to age 24. Anyone taking one should be watched closely for worsening and for new suicidal thoughts or behaviors, especially during the first few months and at times of dosage changes. Don't stop suddenly; talk with your provider first. If you're in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room.
Frequently Asked Questions
What counts as treatment-resistant depression?
The common definition is depression that hasn’t improved enough after at least two antidepressants, each given a fair trial. The definition matters because some trials counted as failures were stopped early for side effects or taken inconsistently. Reconstructing the actual treatment history is usually the first step, and it frequently changes the assessment.
Why have antidepressants not worked for me?
There are several common reasons beyond genuine treatment resistance. The most consequential is an incorrect diagnosis, particularly unrecognized bipolar spectrum disorder, since antidepressants used alone in bipolar disorder may not work and can trigger a manic episode or rapid cycling. Others include trials that were too short, untreated medical contributors such as thyroid or sleep disorders, alcohol use, and ongoing circumstances that medication cannot address. Each of these is worth evaluating before concluding that medication does not work for you.
Is it worth getting a second opinion for depression that is not improving?
Frequently, yes. A second opinion is not a criticism of previous care. Its value is that it revisits the diagnosis and the treatment history with fresh attention, and revisiting the diagnosis sometimes changes the plan. It is reasonable to seek one after two or three fair trials without meaningful improvement.
What are the options if medication has not worked?
Options include adjusting the current medication, switching to a different antidepressant, adding another type of medication, and adding structured psychotherapy if it has not been part of treatment. Brain stimulation treatments such as TMS and ECT are most often used when depression hasn’t improved enough with antidepressant medication, often after two or more trials. ECT may be considered earlier for severe depression, such as when there is psychosis or a high risk of suicide. Insurance coverage criteria vary. Whether a referral makes sense depends on your situation, and your provider will talk with you about all your options.
If you have been through several medication trials without meaningful improvement, the more useful next question is often not which medication to try next, but whether the underlying picture has been fully examined.
The science: how we checked this
Sources
- National Institute of Mental Health: Depression
- National Institute of Mental Health: Bipolar Disorder
- National Institute of Mental Health: Brain Stimulation Therapies
- Rush AJ et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry, 2006
- Okereke OI, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA, 2020
- DailyMed: Esketamine nasal spray, prescribing information
- Szegedi A et al., J Clin Psychiatry 2009: early improvement in the first 2 weeks (meta-analysis)
How we checked this
- Treatment-resistant depression meaning not getting better after at least two antidepressants, antidepressants usually taking 4 to 8 weeks, medical conditions such as thyroid problems causing similar symptoms, adding another type of medication, esketamine's FDA approval, and brain stimulation (ECT and rTMS) when other treatments haven't worked: NIMH, Depression, and NIMH, Brain Stimulation Therapies. The brain stimulation referral sentence is ANK's own wording.
- Antidepressants used alone in bipolar disorder triggering mania or rapid cycling: NIMH, Bipolar Disorder.
- Many people who don't improve on a first antidepressant improving at a later treatment step: the STAR*D study (Rush et al., 2006).
- The checklist and the quiz answers sum up this article's own explanation.
- Not stopping a medication suddenly: our own tapering wording.
- Vitamin D supplements not preventing depression: the VITAL trial (Okereke et al., 2020).
- Esketamine given only in certified treatment centers with monitoring for at least 2 hours: the FDA label (DailyMed).
- Written in our own words from the sources above.




